Malignant Melanoma in Denmark Occurrence and Risk Factors

References

• Cancer incidence in five continents, J Waterhouse, C S Muir, K Shanmugaratnam, I Powell. International Agency for Research on Cancer, Lyon 1982; Vol. IV, (IARC Scientific Publications No. 42)
   Google Scholar
• Magnus K. Incidence of malignant melanoma in the five Nordic countries: significance of solar radiation. Int J Cancer 1977; 20: 477–85
   PubMed Web of Science ®Google Scholar
• Magnus K. Incidence of malignant melanoma of the skin in Norway, 1955–1970. Variation in time and space and solar radiation. Cancer 1973; 32: 1275–86
   PubMed Web of Science ®Google Scholar
• Eklund G, Malec E. Sunlight and incidence of cutaneous malignant melanoma effect of latitude and domicile in Sweden. Scand J Plast Reconstr Surg 1978; 12: 231–41
   PubMed Web of Science ®Google Scholar
• Teppo L, Pakkanen M, Hakulinen T. Sunlight as a risk factor of malignant melanoma of the skin. Cancer 1978; 41: 2018–27
   PubMed Web of Science ®Google Scholar
• Boyle P, Robertson C. Increase in malignant melanoma incidence in Scotland. Am J Epidemiol, (in press)
   Google Scholar
• Hakulinen T, Teppo L, Saxen E. Do the predictions for cancer incidence come true? Experience from Finland. Cancer 1986; 57: 2454–8
   PubMed Web of Science ®Google Scholar
• Lancaster H O, Nelson J. Sunlight as a cause of melanoma: a clinical survey. Med J Aust 1957; 1: 452–6
   Google Scholar
• McGovern V J. Melanoblastoma. Med J Aust 1952; 1: 85–98
   Google Scholar
• Lancaster H O. Some geographical aspects of the mortality from melanoma in Europeans. Med J Aust 1956; 1: 1082–7
   Google Scholar
• Crombie I K. Variation of melanoma incidence with latitude in North America and Europe. Br J Cancer 1979; 40: 774–81
   PubMed Web of Science ®Google Scholar
• Jensen O M, Bolander A M. Trends in malignant melanoma of the skin. World Health Stat Q 1980; 33: 2–26
   PubMedGoogle Scholar
• Østerlind A. Malignant melanoma in Denmark 1943–1977. Ugeskr Laeger 1983; 145: 2335–8, (In Danish.)
   PubMedGoogle Scholar
• Holman C DJ, Mulroney C D, Armstrong B K. Epidemiology of preinvasive and invasive malignant melanoma in Western Australia. Int J Cancer 1980; 25: 317–23
   PubMed Web of Science ®Google Scholar
• Holman D CJ, Armstrong B K, Heenan P J. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. JNCI 1983; 71: 651–6
   PubMedGoogle Scholar
• Magnus K. Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates in Norway 1955–1977 by cohort, sex, age and primary tumour site. Cancer 1981; 48: 2329–35
   PubMed Web of Science ®Google Scholar
• Elwood J M, Hislop T G. Solar radiation in the etiology of cutaneous malignant malanoma in Caucasians. Natl Cancer Inst Monogr 1982; 62: 167–71
   PubMedGoogle Scholar
• Holman C DJ, Armstrong B K, Heenan P J. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. JNCI 1986; 76: 403–14
   PubMed Web of Science ®Google Scholar
• Østerlind A, Hou-Jensen K, Jensen O M. Incidence of cutaneous malignant melanoma in Denmark 1978–1982 Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988; 58: 385–91
   PubMed Web of Science ®Google Scholar
• Østerlind A, Engholm G, Jensen O M. Trends in cutaneous malignant melanoma in Denmark 1943–1982, by anatomic subsite. APMIS 1988; 96: 953–63
   PubMed Web of Science ®Google Scholar
• Jensen O M, Storm H H, Jensen H S. Cancer registration in Denmark and the study of multiple primary cancers, 1943–80. Natl Cancer Inst Monogr 1985; 68: 245–51
   PubMedGoogle Scholar
• Østerlind A, Jensen O M. Evaluation of registration of cancer cases in Denmark in 1977: preliminary evaluation of registration of cancer cases by the Cancer Registry and the National Patient Registry. Ugeskr Laeger 1985; 147: 2485–8, (In Danish)
   Google Scholar
• Storm H H. Completeness of cancer registration in Denmark 1943–1966 and efficacy of record linkage procedures. Int J Epidemiol 1988; 17: 44–9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Manual of the Statistical Classification of Diseases, Injuries and Causes of Death 1955. 7th revision. Geneva 1957
   Google Scholar
• World Health Organization. International Classification of Diseases for Oncology (ICD-O). First edition. Geneva 1976
   Google Scholar
• Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 1987; 6: 449–67
   PubMed Web of Science ®Google Scholar
• Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: The age-period-cohort model. Stat 1987; 6: 469–81
   Web of Science ®Google Scholar
• Elwood J M, Gallagher R P. Site distribution of malignant melanoma. Can Med Assoc J 1983; 128: 1400–4
   PubMed Web of Science ®Google Scholar
• Muir C S, Nectoux J. Time trends: malignant melanoma of the skin. Trends in cancer incidence. Causes and practical implications, K Magnus. Hemisphere, Washington, DC 1982; 365–85
   Google Scholar
• Boyle P, Day N E, Magnus K. Mathematical modelling of malignant melanoma trends in Norway, 1953–78. Am J Epidemiol 1983; 118: 887–96
   PubMed Web of Science ®Google Scholar
• Cancer risk and incidence trends. The Connecticut perspectice, G C Roush, T R Holford, M H Schymura, C White. Hemisphere Publishing, Washington, DC 1987; 203–19
   Google Scholar
• Stevens R G, Moolgavkar S H. Malignant melanoma: dependence of site specific risk on age. Am J Epidemiol 1984; 119: 890–5
   PubMed Web of Science ®Google Scholar
• Lee J AH, Petersen G R, Stevens R G, Vesanen K. The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white populations of the United States. Am J Epidemiol 1979; 110: 734–9
   PubMed Web of Science ®Google Scholar
• Holman C DJ, James I R, Gatley P H, Armstrong B K. An analysis of trends in mortality from malignant melanoma of the skin in Australia. Int J Cancer 1980; 26: 703–9
   PubMed Web of Science ®Google Scholar
• Venzon D J, Moolgavkar S H. Cohort analysis of malignant melanoma in five countries. Am J Epidemiol 1984; 119: 62–70
   PubMed Web of Science ®Google Scholar
• Collins J J, Devine N. Period and cohort factor in the incidence of malignant melanoma in the state of Connecticut. Environ Health Perspect 1984; 56: 255–9
   PubMed Web of Science ®Google Scholar
• Østerlind A, Jensen O M. Increasing incidence of trunk melanoma in young Danish women. Br J Cancer 1987; 55: 467
   PubMed Web of Science ®Google Scholar
• Clark W H, Mihm M C. Lentigo maligna and lentigo-maligna melanoma. Am J Pathol 1969; 55: 39–67
   PubMed Web of Science ®Google Scholar
• Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902–8
   PubMed Web of Science ®Google Scholar
• National Centre for Health Statistics. The person number systems of Sweden, Norway, Denmark, and Israel. HyattsvilleUSA 1980, (Vital Health Statistics. Ser. 2-No. 84. DHHS Publ. PHS 80–1358)
   Google Scholar
• Enevoldsen B, Michelsen N, Friss-Hashe E, Kamper-Jørgensen F. Social classifications, II. Svalastoga's sub-division according to social status rank and the social grouping employed by the Institute for Social Research. Ugeskr Laeger 1980; 142: 544–50, (In Danish.)
   PubMedGoogle Scholar
• Scotto J, Fears T R. Skin cancer epidemiology: research needs. Natl Cancer Inst Monogr 1978; 50: 169–77
   PubMedGoogle Scholar
• Beagley J, Gibson I M. Changes in skin condition in relation to degree of exposure to ultraviolet light. School of Biology, Western Australian Institute of Technology, Perth 1980
   Google Scholar
• Breslow N E, Day N E. Statistical methods in cancer research, Vol. 1, The analysis of case-control studies. International Agency for Research on Cancer, Lyon 1980, (IARC Scientific Publications No. 32)
   Google Scholar
• Thomas D C, Goldberg M, Dewar R, Siemiatycki J. Statistical methods for relating several exposure factors to several diseases in a case-heterogeneity studies. Stat Med 1986; 5: 49–60
   PubMed Web of Science ®Google Scholar
• Cole P, MacMahon B. Attributable risk percent in case-control studies. B J Prev Soc Med 1971; 25: 242–4
   PubMedGoogle Scholar
• Paget J. Report of a clinical lecture on cases of tumours under moles. Medical Times and Gazette 1864, Jan. 16: 58–9
   Google Scholar
• Ackerman A. An exchange of ideas about dysplastic nevi and malignant melanomas. Part A. Am J Dermatopathol 1985; 7(suppl)99–102
   PubMedGoogle Scholar
• Elder D E, Greene M H, Bondi E, Clark W H. Acquired melanocytic nevi and melanoma. The dysplastic nevus syndrome. Pathology of malignant melanoma, A Ackerman. Masson Publishing, New York 1981; 185–215
   Google Scholar
• Pack G T, Davis J, Oppenheim A. The relation of race and complexion to the incidence of moles and melanomas. Ann NY Acad Sci 1963; 100: 719–42
   PubMed Web of Science ®Google Scholar
• Gellin G A, Kopf A W, Garfinkel L. Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol 1969; 99: 43–8
   PubMedGoogle Scholar
• Beardmore G L. The epidemiology of malignant melanoma in Australia. Melanoma and skin cancer, W McCarthy. Government Printer, Sydney 1972; 39–64
   Google Scholar
• Klepp O, Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer 1979; 23: 482–6
   PubMed Web of Science ®Google Scholar
• MacKie R M, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 1982; 46: 955–60
   PubMed Web of Science ®Google Scholar
• Adam S A, Sheaves J K, Wright N H, Mosser G, Harris R W, Vessey M P. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981; 44: 45–50
   PubMed Web of Science ®Google Scholar
• Beral V, Evans S, Shaw H, Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983; 109: 165–72
   PubMed Web of Science ®Google Scholar
• Elwood J M, Gallagher R P, Hill G B, Spinelli J J, Pearson J CG, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J 1984; 288: 99–102
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Armstrong B K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. JNCI 1984; 72: 257–66
   PubMed Web of Science ®Google Scholar
• Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985; 35: 297–300
   PubMed Web of Science ®Google Scholar
• Elwood J M, Williamson C, Stapleton P J. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J cancer 1986; 53: 65–74
   PubMed Web of Science ®Google Scholar
• Sorahan T, Grimley R P. The aetiological significance of sunlight and fluorescent lighting in malignant melanoma: a case-control study. Br J Cancer 1986; 52: 765–9
   Web of Science ®Google Scholar
• Cristofolini M, Franceschi S, Tasin L, et al. Risk factors for cutaneous malignant melanoma in a northern Italian population. Int J Cancer 1987; 39: 150–4
   PubMed Web of Science ®Google Scholar
• Østerlind A, Tucker M A, Hou-Jensen K, Stone B J, Engholm G, Jensen O M. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 1988; 42: 200–6
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr., Reimer R R, Greene M, Ainsworth A M, Mastrangelo M J. Origin of familial melanoma from heritable melanocytic lesions: ‘The B-K mole syndrome’. Arch Dermatol 1978; 114: 732–8
   PubMed Web of Science ®Google Scholar
• Elder D E, Goldman L I, Goldman S C, Greene M H, Clark W H, Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic malignant melanoma. Cancer 1980; 46: 1787–94
   PubMed Web of Science ®Google Scholar
• Nordlund J J, Kirkwood J, Forget B M, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985; 45: 1855–61
   PubMed Web of Science ®Google Scholar
• Swerdlow A J, English J, Mackie R M, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986; 292: 1555–9
   PubMed Web of Science ®Google Scholar
• Roush G C, McKay L, Forget B, Titus L, Kirkwood J. Dependence of total nevi on dysplastic nevi in determining risk for melanoma. Prev Med 1986; 15: 699–700
   Web of Science ®Google Scholar
• Greene M H, Clark W H, Tucker M A, et al. Precursor naevi in cutaneous malignant melanoma. A proposed nomenclature. Lancet 1980; 2: 1024
   PubMed Web of Science ®Google Scholar
• Kelly J W, Crutcher W A, Sagebiel R W. The clinical diagnosis of dysplastic melanocytic nevi—a clinico-pathologic correlation. J Am Acad Dermatol 1986; 14: 1044–52
   PubMed Web of Science ®Google Scholar
• Vesselinovitch Sd, Mihailovich N, Richter W R. The induction of malignant melanomas in Syrian white hamster by neonatal exposure to urethan. Cancer Res 1970; 30: 2543–7
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr., Min B H, Kligman L H. The developmental biology of induced malignant melanoma in guinea pigs and a comparison with other neoplastic systems. Cancer Res 1976; 36: 4079–91
   PubMed Web of Science ®Google Scholar
• Kripke M L. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. JNCI 1979; 63: 541–5
   PubMedGoogle Scholar
• Østerlind A, Tucker M A, Stone B J, Jensen O M. The Danish case–control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 1988; 42: 319–24
   PubMed Web of Science ®Google Scholar
• Elwood J M, Gallagher R P, Davison J, Hill G B. Sunburn, suntan and the risk of cutaneous malignant melanoma. The Western Canada Melanoma Study. Br J Cancer 1985; 51: 543–9
   PubMed Web of Science ®Google Scholar
• Green A, Siskind V, Bain C, Alexander J. Sunburn and malignant melanoma. Br J Cancer 1985; 51: 393–7
   PubMed Web of Science ®Google Scholar
• Lew R A, Sober A J, Cook N, Marvell R, Fitzpatrick T B. Sun exposure habits in patients with cutaneous melanoma: a case–control study. J Dermatol Surg Oncol 1983; 9: 981–6
   PubMedGoogle Scholar
• Armstrong B K, De Klerk N H, Holman C DJ. Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. JNCI 1986; 77: 329–35
   PubMedGoogle Scholar
• Holman C DJ, Armstrong B K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenic types. JNCI 1984; 73: 75–82
   PubMed Web of Science ®Google Scholar
• Elwood J M, Gallagher R P, Hill G B, Pearson J CG. Cutaneous melanoma in relation to intermittent and constant sun exposure—The Western Canada Melanoma Study. Int J Cancer 1985; 35: 427–33
   PubMed Web of Science ®Google Scholar
• English D R, Rouse I L, Xu Z, et al. Cutaneous malignant melanoma and fluorescent lighting. JNCI 1985; 74: 1191–7
   PubMedGoogle Scholar
• Dubin N, Moseson M, Pasternack B S. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation and the identification of high risk populations. Epidemiology of malignant melanoma, R P Gallagher. Springer-Verlag, Heidelberg 1986; 56–75
   Google Scholar
• Beral V, Evans S, Shaw H, Milton G. Malignant melanoma and exposure to fluorescent lighting at work. Lancet 1982; 2: 290–3
   PubMed Web of Science ®Google Scholar
• Walker M J, Beattie C W, Patel M K, Ronan S M, Das Gypta T K. Estrogen receptor in malignant melanoma. J Clin Oncol 1987; 5: 1256–61
   PubMed Web of Science ®Google Scholar
• Østerlind A, Jensen O M. Trends in incidence of malignant melanoma of the skin in Denmark 1943–1982. Epidemiology of malignant melanoma, R P Gallagher. Springer-Verlag, Heidelberg 1986; 8–17
   Google Scholar
• Snell R S, Bischitz P G. The effect of large doses of estrogen and progesterone on melanin pigmentation. J Invest Dermatol 1960; 35: 73–82
   PubMed Web of Science ®Google Scholar
• Holly E A, Weiss N S, Liff J M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. JNCI 1983; 70: 827–31
   PubMedGoogle Scholar
• Beral V, Evans S, Shaw H, Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 1984; 50: 681–5
   PubMed Web of Science ®Google Scholar
• Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977; 36: 804–9
   PubMed Web of Science ®Google Scholar
• Bain C, Hennekens C H, Speizer F E, Rosner B, Willett W, Belanger C. Oral contraceptive use and malignant melanoma. JNCI 1982; 68: 537–9
   PubMed Web of Science ®Google Scholar
• Helmrich S P, Rosenberg L, Kaufman D W, et al. Lack of elevated risk of malignant melanoma in relation to oral contraceptive use. JNCI 1984; 72: 617–20
   PubMedGoogle Scholar
• Holman C DJ, Armstrong B K, Heenan P J. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50: 673–80
   PubMed Web of Science ®Google Scholar
• Gallagher R P, Elwood J M, Hill G B, Coldman A J, Threlfall W J, Spinelli J J. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer 1985; 52: 901–7
   PubMed Web of Science ®Google Scholar
• Green A, Bain C. Hormonal factors and melanoma in women. Med J Aust 1985; 142: 446–8
   PubMed Web of Science ®Google Scholar
• Østerlind A, Tucker M A, Stone B J, Jensen O M. The Danish case–control study of cutaneous melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 1988e; 42: 821–4
   PubMed Web of Science ®Google Scholar
• Kay C R. Malignant melanoma and oral contraceptives. Br J Cancer 1981; 44: 479
   Web of Science ®Google Scholar
• Ewertz M, Duffy S W. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 1988; 58: 99–104
   PubMed Web of Science ®Google Scholar
• Peto R, Doll R, Buckley J D, Sporn M B. Can dietary betacarotene materially reduce human cancer rates?. Nature 1981; 290: 201–8
   PubMed Web of Science ®Google Scholar
• Pinckney E R. The potential toxicity of excessive polyunsaturates. Am Heart J 1973; 85: 723–6
   PubMed Web of Science ®Google Scholar
• Goldrick R B, Goodwin R M, Nestel P J, Davis N C, Poyser A, Quinlivan N L. Do polyunsaturated fats predispose to malignant melanoma?. Med J Aust 1976; 1: 987–9
   PubMed Web of Science ®Google Scholar
• MacKie B S, Johnson A R, MacKie L E, Fogerty A C, Ferris M, Baxter R I. Dietary polyunsaturated fats and malignant melanoma. Med J Aust 1980; 1: 159–62
   PubMed Web of Science ®Google Scholar
• Williams R R. Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, TSH and MSH. Lancet 1976; 1: 996–9
   PubMed Web of Science ®Google Scholar
• Williams R R, Horm J W. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. JNCI 1977; 58: 525–47
   PubMed Web of Science ®Google Scholar
• Paffenbarger R S, Wing A L, Hyde R T. Characteristics of youth predictive of adult-onset malignant lymphomas, melanomas and leukemias. JNCI 1978; 60: 89–92
   PubMed Web of Science ®Google Scholar
• Holman C DJ. Risk factors in the causation of human malignant melanoma of the skin. Dissertation, University of Western Australia, Perth 1983
   Google Scholar
• Holman C DJ, Armstrong B K. Hutchinson's melanotic freckle melanoma associated with non-permanent hair dyes. Br J Cancer 1983; 48: 599–601
   PubMed Web of Science ®Google Scholar
• O'Rourke D A. Excessive washing and melanoma. Med J Aust 1981; 2: 684
   Google Scholar
• MacKie B S. Excessive washing and melanoma. Med J Aust 1981; 1: 258
   PubMedGoogle Scholar
• Østerlind A, Tucker M A, Stone B J, Jensen O M. The Danish case–control study of cutaneous melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer 1988; 42: 825–8
   PubMed Web of Science ®Google Scholar
• Shaw H M, Milton G W. Smoking and the development of metastases from malignant melanoma. Int J Cancer 1981; 28: 153–6
   PubMed Web of Science ®Google Scholar